Location History:
- Glasgow, GB (2001 - 2002)
- East Kilbride, GB (2006 - 2016)
Company Filing History:
3 out of 1,500 
1 out of 107 
1 out of 2,405 
Years Active: 2001-2016
Title: Unveiling the Innovations of Inventor Andrew Cooke from East Kilbride, GB
Introduction:
Andrew Cooke, a prolific inventor hailing from East Kilbride, GB, has made significant contributions in the field of pharmaceuticals with a total of 7 patents to his name.
Latest Patents:
His recent patents include groundbreaking inventions such as Aldosterone Synthase Inhibitors and 1-(4-ureidobenzoyl)piperazine derivatives. The former targets disorders associated with elevated aldosterone levels, offering potential treatment avenues for conditions like hypertension and heart failure. While the latter focuses on combating atherosclerosis and related disorders associated with cholesterol and bile acids transport and metabolism.
Career Highlights:
With an impressive portfolio of patents, Andrew Cooke has demonstrated a keen understanding of pharmaceutical innovation. Having worked with esteemed companies like AstraZeneca Ab and Astra Zeneca U.K. Limited, he has showcased his expertise in developing novel compounds for therapeutic purposes.
Collaborations:
Throughout his career, Andrew Cooke has collaborated with notable individuals in the field, including David R Cheshire and Martin E Cooper. These partnerships have been instrumental in advancing his research and bringing innovative solutions to the forefront of pharmaceutical development.
Conclusion:
Inventor Andrew Cooke's pioneering work in the realm of pharmaceuticals stands as a testament to his ingenuity and dedication to driving progress in healthcare. His inventive spirit and collaborative efforts continue to shape the landscape of innovation, offering promising solutions for various medical challenges.